Shorla wins FDA approval for leukaemia drug
The Clonmel-headquartered start-up specialises in developing innovative oncology drugs, with a focus on orphan and paediatric cancers.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
